AF
ANIK icon

Allworth Financial’s Anika Therapeutics ANIK Stock Holding History

Allworth Financial’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.5K Buy
991
+657
+197% +$9.74K ﹤0.01% 3452
2026
Q1 		$4.84K Buy
334
+324
+3,240% +$3.76K ﹤0.01% 3980
2025
Q4 		$97 Sell
10
-1
-9% -$10 ﹤0.01% 4785
2025
Q3 		$104 Sell
11
-1
-8% -$10 ﹤0.01% 4674
2025
Q2 		$127 Buy
+12
New +$151 ﹤0.01% 4372

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

Allworth Financial's ANIK Position: Q2 2026 in Review

Allworth Financial increased its Anika Therapeutics (ANIK) stake by 197% in Q2 2026, buying an estimated $9.74K and bringing the position to 991 shares worth $14.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3452.

Allworth Financial first reported a position in ANIK in Q2 2025 and has held it in 5 quarters since. 133 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

  • Allworth Financial held 991 shares of Anika Therapeutics worth $14.5K as of Q2 2026.
  • Allworth Financial bought 657 Anika Therapeutics shares in Q2 2026, an estimated $9.74K.
  • Anika Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3452 holding.
  • Allworth Financial first reported a position in Anika Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 133 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.